By Marie Rosenthal
In a unanimous vote, 19 members of the FDA Vaccines and Related Biological Products Advisory Committee recommended boosters for the Moderna COVID-19 vaccine.
The recommendation will affect a large group of people in the United States. VRBPAC voted to recommend an expansion of Moderna’s emergency use authorization (EUA) for its messenger RNA (mRNA) vaccine for those who are:
- 65 years and older;
- 18 to 64 years of age with a high risk for severe COVID-19; and
- 18 to 64 years of